Science
Nanostics and Protean BioDiagnostics Partner to Launch CDX Prostate for Men at Risk of Having Aggressive Prostate Cancer in the United States
CDX Prostate is a blood-based diagnostic tool that uses AI-powered learning to determine the risk of aggressive prostate cancer. Florida-based Protean BioDiagnostics will now offer the validated CDX Prostate risk score to healthcare providers and the
By: financialpost
- Sep 25 2024
- 0
- 0 Views
ONLY AVAILABLE IN PAID PLANS